Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Aquestive Therapeutics Shares Up on Pipeline Update and Raised Full-Year 2019 Guidance

Aquestive Therapeutics shares traded 20% higher today after the firm reported Q3/19 earnings and raised its FY/19 guidance. The firm states it expects to complete its NDA for Libervant buccal film near the end of this month. Yesterday afternoon, specialty pharmaceutic...
Streetwise Reports | November 7, 2019 |

Own Them All - The Next Media Juggernaut

Since its release in 2009, James Cameron’s Avatar has held the all-time box office record for nearly a decade. With a budget of $300 million and an additional $150 million for marketing, Avatar’s total cost of $450 million was made back several times. The big...
Marin Katusa | May 10, 2019 |

'Undervalued' Biopharma Features Robust Pipeline, Future Upside

The case for investing in this company was made in an H.C. Wainwright & Co. report. In an April 22, 2019 research note, analyst Ram Selvaraju reported that H.C. Wainwright & Co. initiated coverage on Aquestive Therapeutics Inc. (AQST:NASDAQ) , "an undervalued spec...
Streetwise Reports | April 29, 2019 |

The Golden Bullet for Drug Delivery

It’s the Holy Grail in the cannabis industry. Everyone is trying to innovate the best delivery system to optimize the “bioavailability” (uptake) of medical cannabis in order to offer the perfect pairing -- precise dosing with a fast on...
Marc Davis | January 8, 2020 |

Gilead, Teva, XPhyto - Global marketing potential

The best business models solve problems and are scalable. In this context, the healthcare sector is particularly interesting. The world's population has recently reached 7.8 billion people and for this reason solutions can meet a large potential market with users. Cross-border...
Mario Hose | June 16, 2020 |

XPhyto: The Cutting Edge of Medical Cannabis Science

At the forefront of the next wave of cannabis commercialization, is a German-focused company with headquarters in Vancouver, XPhyto Therapeutics Corp. (CSE: XPHY; FSE: 4XT) , that is building a much-coveted cannabis R&D cultivation facility in a converted nuclear bunker and o...
Marc Davis | November 12, 2019 |

Buzz on the Bullboards: The Talked About Cannabis & Health Stocks This Summer

(Image via Canopy Growth Corp.) “Puff puff, pass” might be a thing of the past. The world’s biggest cannabis producer, Canopy Growth Corp. ( TSX: WEED , Forum ) launched two new products this week - Tweed Qu...
Stockhouse Editorial | July 28, 2021 |

Buzz on the Bullboards: Hot Summer Stocks Ahead of the Autumn Rush

(Image via Bombardier Inc.) Investors, our audience, and even some executives regularly visit this site to see how their companies and investing strategies are faring in the community. This week, our highlights go to the newer (and returning) companies that have...
Stockhouse Editorial | September 1, 2021 |

Buzz on the Bullboards: A Bigger Picture for Smaller Caps

(Image via Blackberry Ltd.) The business of war weighs on the minds of investors and companies today. It is not just that, but the push to re-emerge from the COVID-19 pandemic to supply chain issues, business has been adapting. Take BlackBerry Limited ( TSX: BB...
Stockhouse Editorial | March 23, 2022 |

Sitka Gold: Exploring gold, silver and copper properties of merit

Our next company is a well-funded mineral exploration company focused on exploring economically viable mineral deposits. Sitka Gold has four projects, but today we will dive into the RC Gold Project in the Yukon and the Alpha Gold Property in Nevada to see what&CloseC...
Brieanna McCutcheon | March 27, 2023 |
1 2 3 4 5 6